Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA

Posttransplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis is an effective strategie for patients receiving matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) and haploidentical HSCT (haplo-HSCT). We evaluated the effectiveness and safety of reduced-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zu, Yingling, Zhou, Jian, Fu, Yuewen, Fang, Baijun, Liu, Xinjian, Zhang, Yanli, Yu, Fengkuan, Zuo, Wenli, Zhou, Hu, Gui, Ruirui, Li, Zhen, Liu, Yanyan, Zhao, Huifang, Zhang, Chengjuan, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794355/
https://www.ncbi.nlm.nih.gov/pubmed/33420287
http://dx.doi.org/10.1038/s41598-020-80531-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794355/
https://www.ncbi.nlm.nih.gov/pubmed/33420287
http://dx.doi.org/10.1038/s41598-020-80531-7

Ejemplares similares